Search by Drug Name or NDC
NDC 16252-0540-01 Isradipine 5 mg/1 Details
Isradipine 5 mg/1
Isradipine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is ISRADIPINE.
MedlinePlus Drug Summary
Isradipine is used to treat high blood pressure. Isradipine is in a class of medications called calcium channel blockers. It works by relaxing the blood vessels so your heart does not have to pump as hard. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 16252-0540-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Isradipine
Product Information
| NDC | 16252-0540 |
|---|---|
| Product ID | 16252-540_7d8fbb2a-23a9-44d8-9956-167d775a6aa6 |
| Associated GPIs | 34000015000120 |
| GCN Sequence Number | 015889 |
| GCN Sequence Number Description | isradipine CAPSULE 5 MG ORAL |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 02612 |
| HICL Sequence Number | 006063 |
| HICL Sequence Number Description | ISRADIPINE |
| Brand/Generic | Generic |
| Proprietary Name | Isradipine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Isradipine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | ISRADIPINE |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077317 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 16252-0540-01 (16252054001)
| NDC Package Code | 16252-540-01 |
|---|---|
| Billing NDC | 16252054001 |
| Package | 100 CAPSULE in 1 BOTTLE (16252-540-01) |
| Marketing Start Date | 2006-01-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |